Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

NCT00128622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Lung Cancer
Pancreatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: denileukin diftitox
BIOLOGICAL: recombinant fowlpox-CEA(6D)/TRICOM vaccine
BIOLOGICAL: therapeutic autologous dendritic cells

Sponsor

H. Kim Lyerly

Collaborators

[object Object]